RPS6

Small ribosomal subunit protein eS6 · P62753 · RPS6 on Sugi Atlas →

0 patent compounds predicted against RPS6, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RPS6 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer PHASE1/PHASE2COMPLETED
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma PHASE1/PHASE2COMPLETED
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety PHASE2COMPLETED
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis PHASE1/PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE1WITHDRAWN
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment PHASE1COMPLETED
Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer EARLY_PHASE1COMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS) nanRECRUITING
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses nanRECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
The Effects of Whey vs. Collagen on MPS nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Protein Intake and Step Reduction in Older Adults nanCOMPLETED
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory nanCOMPLETED
The Correlation Between Anemia of Chronic Diseases, Hepcidin and Vitamin D in IBD Patients nanUNKNOWN
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN

Related proteins — ESM-2 sequence neighbours (a RPS6 binder may also engage these)

ProteinNameSimilarity
P62754 1.000 P62754 →
Q4R4K6 1.000 Q4R4K6 →
Q9YGF2 1.000 Q9YGF2 →
P29327 1.000 P29327 →
P39017 1.000 P39017 →
G1TM55 1.000 G1TM55 →
Q9C0Z7 1.000 Q9C0Z7 →
Q90YR8 1.000 Q90YR8 →
O01727 1.000 O01727 →
P47838 1.000 P47838 →
P62755 1.000 P62755 →
P0CX37 1.000 P0CX37 →
P0CX38 1.000 P0CX38 →
Q6CM04 1.000 Q6CM04 →
Q5E995 1.000 Q5E995 →
Q9BMX5 1.000 Q9BMX5 →
O48549 1.000 O48549 →
O44012 0.999 O44012 →
P51430 0.999 P51430 →
A0A1D8PL99 0.998 A0A1D8PL99 →
P05752 0.998 P05752 →
P41798 0.998 P41798 →
Q6FJH3 0.998 Q6FJH3 →
Q54UU3 0.998 Q54UU3 →
Q94624 0.996 Q94624 →
Q95V32 0.995 Q95V32 →
Q74ZK3 0.995 Q74ZK3 →
Q6BXH8 0.995 Q6BXH8 →
Q6C169 0.994 Q6C169 →
Q8SRY0 0.994 Q8SRY0 →